Aspire Biopharma Statistics Share Statistics Aspire Biopharma has 49.53M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 49.53M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 18.49% Shares Floating n/a Failed to Deliver (FTD) Shares 20,163 FTD / Avg. Volume 0.17%
Short Selling Information The latest short interest is 1.29M, so 2.6% of the outstanding
shares have been sold short.
Short Interest 1.29M Short % of Shares Out 2.6% Short % of Float 3.64% Short Ratio (days to cover) 2.98
Valuation Ratios The PE ratio is -7.57 and the forward
PE ratio is null.
Aspire Biopharma's PEG ratio is
0.
PE Ratio -7.57 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -61.61 P/FCF Ratio -357.83 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aspire Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.09,
with a Debt / Equity ratio of -0.82.
Current Ratio 0.09 Quick Ratio 0.09 Debt / Equity -0.82 Debt / EBITDA -0.11 Debt / FCF -4.78 Interest Coverage -3.46
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-6.27M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.01K Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.8, so Aspire Biopharma's
price volatility has been higher than the market average.
Beta 0.8 52-Week Price Change n/a 50-Day Moving Average 0.38 200-Day Moving Average n/a Relative Strength Index (RSI) 61.91 Average Volume (20 Days) 12,116,417
Income Statement
Revenue n/a Gross Profit n/a Operating Income -3.09M Net Income -12.54M EBITDA -11.65M EBIT -11.65M Earnings Per Share (EPS) -1.52
Full Income Statement Balance Sheet The company has 3.63K in cash and 1.27M in
debt, giving a net cash position of -1.26M.
Cash & Cash Equivalents 3.63K Total Debt 1.27M Net Cash -1.26M Retained Earnings -2.78M Total Assets 1.97M Working Capital -6.9M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -265.19K
and capital expenditures 0, giving a free cash flow of -265.19K.
Operating Cash Flow -265.19K Capital Expenditures n/a Free Cash Flow -265.19K FCF Per Share -0.03
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
